Obenshain Andrew

President and CEO, Directorbluebird bio, Inc. (BLUE) · full profile →Form 4 · filed Mar 5, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$9K
Net Open-Market Flow
-$9K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2024Sell(S)6K$1.53$9K280K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 1, 2024Grant(A)650K$0650K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-24-002306) within minutes of acceptance. Every field above traces to the original document. Verify it directly: